Cardiac Amyloidosis in the Setting of a Sarcomatous Pericardial Mass
Article in Cureus (June 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Patisiran, an RNAi therapeutic for patients with hereditary transthyretin‐mediated amyloidosis: Sub‐analysis in Japanese patients from the APOLLO study
Article in Neurology and Clinical Neuroscience (July 2020)
Riociguat for the treatment of transthyretin cardiac amyloidosis: data from a named patient use program in Austria
Article in Pulmonary Circulation (October 2019)